                <div id="tab-4">
                  <div class="tab-list main-scroll">
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">Muracol protect, Bulgaria</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40’s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">GcMAF</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>his way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">Chondroitine Sulphate</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40’s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">GA-40, Georgia</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40’s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">Hydrogen water</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40’s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">Cesium Chloride</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40’s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                    <div class="tab-item">
                      <div class="tab-item__head">
                        <label class="tab_head_check">
                          <input class="checkbox" type="checkbox"><span class="checkbox-custom"></span>
                          <p class="title">Sulphoraphane</p>
                        </label>
                        <div class="arrow"><img src="img/svg/dropdown-ico.svg" alt=""></div>
                      </div>
                      <div class="tab-item__content">
                        <div class="text">
                          <p>The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40’s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific.This part of the book describes the results</p>
                        </div><a class="show-more" href="javascript:void(0)">Show more</a><a class="link" href="javascript:void(0)">GA-40 A New Immunotherapeutic &amp; Anti-Cancer Drug </a>
                      </div>
                    </div>
                  </div>
                </div>
